GURUGRAM, India , Oct. 4, 2023 /PRNewswire/ -- From Zika Virus to outbreaks of Dengue & Chikungunya, POC Immunoassays Analyzers (IAA) have played a crucial role in diagnosing illness. Along with rapid technological advancements in Brazil, this market is scaling higher demand due to its fast & accurate testing results
STORY OUTLINE
POC IAA Testing Advantages: Swift and effective diagnostics for chronic diseases, extending access beyond hospitals and clinics.
Technological Advancements: Improved POC IAA devices drive widespread adoption in Brazil's healthcare.
Diabetes Monitoring: POC glucose testing vital for diabetes management, offering remote monitoring and advanced care.
Impactful Outbreak Response: Rapid test kits reduce dengue, Zika, and chikungunya cases in Brazil.
Improved Healthcare Access: POC IAA extends diagnostics to physician's offices, homes, ambulances, and field settings.
POC diagnostics offer numerous advantages compared to traditional methods, enabling patient diagnosis in various locations beyond hospitals and clinics. These locations include physician's offices, ambulances, homes, field settings, and hospitals. Among the commonly performed tests in Brazil, measuring blood glucose levels stands out as one of the most prevalent diagnostic procedures. POC testing, also referred to as bedside testing, near-patient testing, remote testing, mobile testing, or rapid diagnostics, involves medical testing conducted outside of a traditional laboratory setting.
Interested to Know More about this Report,
Request a Free Sample Report
1. POC IAA Testing: A Game-Changer in Brazil's Chronic Disease Fight
In Brazil, the country has encountered several infectious disease outbreaks in the past, such as Zika virus, dengue, and chikungunya. The availability of rapid diagnostic test kits, including those supplied by Wondfo, has played a crucial role in promptly diagnosing these diseases and effectively managing their spread.
The demand for efficient and swift diagnostic methods has increased in response to the rising prevalence of chronic diseases like diabetes, thyroid disorders, and autoimmune conditions. Point-of-care immunoassay tests (POC IAA) have emerged as a favored option among both healthcare providers and patients, as they offer quick results, enabling timely diagnosis and better management of these conditions.
WHO's revelation that one in three adults worldwide is affected by obesity, along with IDF's report of 463 million adults with diabetes and AARDA's estimation of 23.5 million autoimmune cases in the US, highlight the scale and seriousness of these health challenges.
2. Tech Breakthroughs Reshape POC IAA Market in Brazil
Ongoing advancements in technology have led to the development of more accurate, sensitive, and user-friendly POC IAA testing devices. Improved technology encourages healthcare facilities and professionals to adopt POC IAA testing, leading to market growth.
Monitoring devices offer advanced care, mobile monitoring, and drug details to patients. They range from health statistics monitoring to remote testing, enabling healthcare staff to share results with professionals.
Diabetes is a major application area for POC IAA tests. POC glucose testing is a prominent application of POC IAA devices. The market for POC glucose testing is projected to grow.
Visit this Link :-
Request for custom report
3. Rapid Test Kits Revolutionize Outbreak Response in Brazil
Utilizing rapid test kits in Brazil led to an impressive ~90% reduction in dengue cases, expediting early diagnosis and intervention, and curbing the spread of the disease (BioMed Research International).
With a remarkable 95% accuracy rate, rapid test kits provided timely identification of Zika virus infections, enabling prompt isolation and treatment measures in affected individuals (BMJ Journals).
Rapid tests played a vital role in Brazil's efforts to combat chikungunya, facilitating targeted interventions that led to a significant 70% reduction in transmission rates of the disease (PLOS Neglected Tropical Diseases)
In conclusion, Point-of-Care (POC) IAA testing has emerged as a game-changer in Brazil's healthcare landscape, offering numerous advantages over traditional methods. With the support of advanced technology and rapid test kits, the country has been able to respond effectively to infectious disease outbreaks and tackle the rising prevalence of chronic conditions like diabetes. POC IAA testing's accessibility and convenience have transformed patient diagnosis, making a significant impact on healthcare outcomes in various settings beyond hospitals and clinics. As technology continues to evolve, the POC IAA market in Brazil is poised for further growth and innovation in the healthcare sector.
According to
Ken Research, strong future growth for the
POC IAA market in Brazil, driven by increasing chronic diseases, technological advancements, and the demand for accessible and rapid diagnostics in diverse healthcare settings. As POC IAA testing becomes increasingly integral to Brazil's healthcare system, investment in innovative technologies and strategic partnerships are anticipated to fuel sustained growth in the market.
Market Taxonomy
Brazil POC Immunoassays Analyzer Market Segmentation
Boditech Market Segmentation
By Hospital ICU Bed Capacity
20 beds or less
20-50 beds
50 beds and above
Request free 30 minutes analyst call
Biomerieux Market Segmentation
By Hospital ICU Bed Capacity
20 beds or less
20-50 beds
50 beds and above
Wondfo Market Segmentation
By Hospital ICU Bed Capacity
20 beds or less
20-50 beds
50 beds and above
For More Insights On Market Intelligence, Refer To The Link Below: –
Brazil POC Immunoassay Analyzers Market
Related Reports by Ken Research: –
Qatar Blood Gas Analyzer, POC Immunoassay Analyzer and Transcutaneous Monitors Market Outlook to 2026 Driven by Huge state investment are fueling the specialized healthcare facilities of Qatar with a vision to develop fully equipped healthcare system
Factors such as high disease prevalence, growing tourism industry, growing healthcare infrastructure, and improving quality of healthcare services will drive the Diagnostic Device (BGA, POC IAA, and TCM) Market in Qatar shortly in terms of installations and Revenue.
Morocco Blood Gas Analyzer and POC and Immunoassay Analyzer Market Outlook to 2026 Driven by Construction of new hospitals along with high focus on rapid diagnostics and other hospital consumables is expected to benefit Moroccan healthcare system in future
Factors such as technological implementations, new testing techniques, growing healthcare infrastructure in Morocco, increasing healthcare spending, and improving quality of services in healthcare facilities will drive the Blood Gas Analyzer and POC Immunoassay Analyzer in Morocco shortly both in terms of revenue and installed units.
Oman Blood Gas Analyzer, POC Immunoassay Analyzer, and Transcutaneous Monitors Market Outlook to 2026 Driven by Remarkable growth in the distribution and quality of health services has added to previous health achievements made during the renaissance in Oman
Factors such as high disease prevalence, shifting from Central Lab devices to POC, technological innovations, growing healthcare infrastructure, and improving quality of healthcare services will drive the Diagnostic Device (BGA, POC IAA, and TCM) Market in Oman shortly in terms of installations.
India POC Immunoassay Analyzers Market Competition Benchmarking for Point of Care Immunoassay Analysers in India
India is one of the fastest-growing economies in the world, and this growth extends to its healthcare sector as well. The country had been steadily expanding its healthcare infrastructure and capabilities, particularly in response to the COVID-19 pandemic.
Follow Us –
LinkedIn
|
Instagram
|
Facebook
|
Twitter
|
YouTube
Contact Us:-
Ken Research Private Limited
Ankur Gupta, Director Strategy and Growth
[email protected]
+91-9015378249
Logo:
SOURCE Ken Research
